Last update:
Weight management news
GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out ...
9 hours ago
0
7
Stopping GLP-1 drugs can quickly erase cardiovascular benefits
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...
16 hours ago
0
7
Free summer camp helps close the gap in healthy behaviors for kids, study finds
Researchers from the Arnold Healthy Kids Initiative and Research Center for Child Well-Being have continued publishing results from their three-year study examining the health effects of providing free summer camp for children ...
11 hours ago
0
3
What is 'eye stroke' and why has it been linked to weight loss injections?
The phrase "eye stroke" has recently appeared in news reports about a very rare side effect of weight-loss injections. It's not a formal medical diagnosis, but a shorthand used to describe a condition in which reduced blood ...
15 hours ago
0
4
GLP-1 drugs and pregnancy: Who may face higher preterm birth risk
Weight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early pregnancy to treat pre-existing diabetes. However, a large study of over 750,000 ...
Mar 17, 2026
0
4
Extra belly weight, not BMI, is a stronger predictor of heart failure risk, inflammation: Study
New research suggests that measures of excess weight around the waist (central obesity or visceral fat) may increase the risk of heart failure primarily due to inflammation, according to findings presented at the American ...
Mar 17, 2026
0
6
Recommendations developed for faltering weight in children
In a clinical practice guideline issued by the American Academy of Pediatrics, in partnership with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, recommendations are presented for the ...
Mar 17, 2026
0
2
Type 2 diabetes risk found to vary widely among adults 18–40 with prediabetes
A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for those with the highest risk of developing type 2 diabetes, according to ...
Mar 17, 2026
0
3
Experts warn mothers and babies are at growing risk without better care for type 2 diabetes
Researchers from across the UK and Ireland are calling for urgent action to improve care for women with early-onset type 2 diabetes before, during, and after pregnancy. The call follows a new consensus statement developed ...
Mar 17, 2026
0
2
Research finds links among work, diet and chronic illnesses
Two related studies published recently by international teams—including researchers with the UCLA Fielding School of Public Health and the UCLA Joe C. Wen School of Nursing—examined how diabetes, heart disease and other ...
Mar 17, 2026
0
4
New genetic risk score better predicts diabetes, obesity and downstream complications
Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic features. A polygenic risk score (PRS) can capture multiple genetic risk factors to provide an estimate ...
Mar 16, 2026
0
5
Concerning rise in US teen obesity over a decade
Nearly 1 in 5 teens in the United States is obese, putting their long-term health at serious risk. Obesity in adolescence leads to many deleterious medical conditions including diabetes, high blood pressure, sleep apnea, ...
Mar 16, 2026
0
4
Obesity, treatment, and shame: What women really think about pharmacotherapy
Obesity is increasingly referred to as a chronic disease. This is also how it is defined in the recommendations of scientific societies. In practice, however, many women who decide to undergo pharmacological treatment still ...
Mar 16, 2026
0
2
Fat cells burn energy to make heat, making them the next frontier of weight loss therapies
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and feel full sooner. Their ...
Mar 14, 2026
0
9
What happens when patients stop taking GLP-1 drugs? New study reveals real world insights
As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 patients suggests that discontinuing ...
Mar 13, 2026
0
10
Experts propose a tobacco playbook for food policy
Diet‑related diseases such as type 2 diabetes, obesity and hypertension, particularly those affecting children, remain stubbornly high. Can public policies like those that have been successful with tobacco control help ...
Mar 13, 2026
0
6
Excessive smartphone use associated with symptoms of eating disorder and body dissatisfaction in young people
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that excessive smartphone use is closely associated with disordered eating, including uncontrolled eating ...
Mar 13, 2026
0
6
AI meal plans for teens may undercount calories by nearly 700, study suggests
Many teens dealing with weight issues are turning to AI models to help them create meal plans with the aim of losing weight. But a new study shows that the resulting plans may not always adequately cover necessary nutrients ...
Mar 12, 2026
0
12
A new tool to predict physical health risks in young people with psychosis
A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes.
Mar 11, 2026
0
7
Q&A: How small steps can help GLP-1 users build healthier habits
A Stanford study shows simple digital prompts can motivate people taking GLP-1 medications to make lifestyle changes. It's a simple premise: What if something as small as a digital nudge could put someone on the path to healthier ...
Mar 11, 2026
0
6
Study links higher asprosin to less weight gain after menopause
Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the hormone asprosin influences long-term weight change among postmenopausal women in the United States. ...
Mar 11, 2026
0
7
Wegovy may have highest 'eye stroke' and sight loss risk among semaglutide GLP-1 agonists
Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published ...
Mar 10, 2026
0
64
GLP-1 medication changes may support long-term weight management
Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to a new study by UT Southwestern ...
Mar 10, 2026
0
9
Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes ...
Mar 10, 2026
0
16
2018 to 2025 saw rise in GLP-1 receptor agonist Rx for bariatric surgery-eligible patients
Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescriptions increased from 2018 to 2025, while MBS use decreased beginning in 2023, according to a research ...
Mar 10, 2026
0
3
